BeiGene, Ltd. Quarterly Debt-to-equity in % from Q3 2016 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: BeiGene, Ltd. quarterly Debt-to-equity history and growth rate from Q3 2016 to Q4 2024.
BeiGene, Ltd. Debt-to-equity for the quarter ending December 31, 2024 was 71.4 %, a 40.4% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	71.4	+20.6	+40.4%	Dec 31, 2024
Q3 2024	68	+21.5	+46.2%	Sep 30, 2024
Q2 2024	61.9	+16	+34.9%	Jun 30, 2024
Q1 2024	57.2	+14	+32.4%	Mar 31, 2024
Q4 2023	50.9	+9.49	+22.9%	Dec 31, 2023
Q3 2023	46.5	+6.58	+16.5%	Sep 30, 2023
Q2 2023	45.9	+4.12	+9.87%	Jun 30, 2023
Q1 2023	43.2	-1.26	-2.84%	Mar 31, 2023
Q4 2022	41.4	-5.8	-12.3%	Dec 31, 2022
Q3 2022	39.9	-9.93	-19.9%	Sep 30, 2022
Q2 2022	41.8	-0.97	-2.27%	Jun 30, 2022
Q1 2022	44.4	+2.42	+5.76%	Mar 31, 2022
Q4 2021	47.2	+5.72	+13.8%	Dec 31, 2021
Q3 2021	49.9	+7.38	+17.4%	Sep 30, 2021
Q2 2021	42.7	-7.58	-15.1%	Jun 30, 2021
Q1 2021	42	-3.99	-8.67%	Mar 31, 2021
Q4 2020	41.5	-2.03	-4.67%	Dec 31, 2020
Q3 2020	42.5	+6.68	+18.7%	Sep 30, 2020
Q2 2020	50.3	+20.5	+68.7%	Jun 30, 2020
Q1 2020	46	+17	+58.3%	Mar 31, 2020
Q4 2019	43.5	+16.4	+60.4%	Dec 31, 2019
Q3 2019	35.8	+5.68	+18.9%	Sep 30, 2019
Q2 2019	29.8	-5.98	-16.7%	Jun 30, 2019
Q1 2019	29.1	-10.7	-26.9%	Mar 31, 2019
Q4 2018	27.1	-19.2	-41.5%	Dec 31, 2018
Q3 2018	30.1	-6.46	-17.7%	Sep 30, 2018
Q2 2018	35.8	+2.08	+6.17%	Jun 30, 2018
Q1 2018	39.8	+21.1	+113%	Mar 31, 2018
Q4 2017	46.3	+31	+202%	Dec 31, 2017
Q3 2017	36.6	+10.5	+40.1%	Sep 30, 2017
Q2 2017	33.7			Jun 30, 2017
Q1 2017	18.7			Mar 31, 2017
Q4 2016	15.3			Dec 31, 2016
Q3 2016	26.1			Sep 30, 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.